News | August 11, 2021
Cadila Healthcare net profit at Rs 587.2 cr in Q1FY22
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
It is designed to tackle mental health issues
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Be One is a 100% Ayurvedic health and wellness supplement.
Subscribe To Our Newsletter & Stay Updated
